Price T Rowe Associates Inc Lannett CO Inc Transaction History

Price T Rowe Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.93 $52,416 - $98,448	-33,600 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.17 - $5.74 $30,224 - $41,603	7,248 Added 27.5%	33,600 $157,000
Q1 2021 May 17, 2021	BUY	$5.28 - $9.64 $139,138 - $254,033	26,352 New	26,352 $139,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.